GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Jibeier Pharmaceutical Co Ltd (SHSE:688566) » Definitions » Stock Based Compensation

Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Stock Based Compensation : ¥0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Jiangsu Jibeier Pharmaceutical Co Stock Based Compensation?

Jiangsu Jibeier Pharmaceutical Co's Stock Based Compensation for the three months ended in Mar. 2024 was ¥0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.0 Mil.


Jiangsu Jibeier Pharmaceutical Co Stock Based Compensation Historical Data

The historical data trend for Jiangsu Jibeier Pharmaceutical Co's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Jibeier Pharmaceutical Co Stock Based Compensation Chart

Jiangsu Jibeier Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Stock Based Compensation
Get a 7-Day Free Trial - - - - -

Jiangsu Jibeier Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Jiangsu Jibeier Pharmaceutical Co Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.


Jiangsu Jibeier Pharmaceutical Co Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Jiangsu Jibeier Pharmaceutical Co's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Business Description

Traded in Other Exchanges
N/A
Address
High-tech Industrial Development Zone, Jiangsu Province, Zhenjiang, CHN, 212000
Jiangsu Jibeier Pharmaceutical Co Ltd specializes in the research, development, production and sales of chemical preparations, proprietary Chinese medicine preparations, and bulk medicines. The company's products include tablets, hard capsules, eye drops, and gels, agents, creams and other dosage. Its products are used in various application fields such as Cardiovascular drugs, Blood system drugs, Immune system drugs, Ophthalmic drugs, Antipyretic and analgesic drugs, Respiratory medicine, and other.
Executives
Wu Ying senior management
Zhang Chun Director
Zhao Suo Fu senior management
Li Hai Dao Core technical personnel
Di Jian Zhong senior management
Qin Xu Feng Core technical personnel
Wu Xiu Gen Core technical personnel
Yu Xin Jun Directors, senior managers
Hu Tao Director

Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Headlines

No Headlines